vs
Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and Vericel Corp (VCEL). Click either name above to swap in a different company.
CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $92.9M, roughly 1.1× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs 11.6%, a 13.4% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 8.0%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $6.2M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 1.0%).
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
CSV vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $105.5M | $92.9M |
| Net Profit | $12.3M | $23.2M |
| Gross Margin | 34.8% | 78.7% |
| Operating Margin | 23.3% | 24.1% |
| Net Margin | 11.6% | 25.0% |
| Revenue YoY | 8.0% | 23.3% |
| Net Profit YoY | 24.5% | 17.3% |
| EPS (diluted) | $0.76 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.5M | $92.9M | ||
| Q3 25 | $102.7M | $67.5M | ||
| Q2 25 | $102.1M | $63.2M | ||
| Q1 25 | $107.1M | $52.6M | ||
| Q4 24 | $97.7M | $75.4M | ||
| Q3 24 | $100.7M | $57.9M | ||
| Q2 24 | $102.3M | $52.7M | ||
| Q1 24 | $103.5M | $51.3M |
| Q4 25 | $12.3M | $23.2M | ||
| Q3 25 | $6.6M | $5.1M | ||
| Q2 25 | $11.7M | $-553.0K | ||
| Q1 25 | $20.9M | $-11.2M | ||
| Q4 24 | $9.9M | $19.8M | ||
| Q3 24 | $9.9M | $-901.0K | ||
| Q2 24 | $6.3M | $-4.7M | ||
| Q1 24 | $7.0M | $-3.9M |
| Q4 25 | 34.8% | 78.7% | ||
| Q3 25 | 35.3% | 73.5% | ||
| Q2 25 | 35.2% | 73.7% | ||
| Q1 25 | 35.3% | 69.0% | ||
| Q4 24 | 34.4% | 77.6% | ||
| Q3 24 | 35.2% | 71.9% | ||
| Q2 24 | 36.2% | 69.5% | ||
| Q1 24 | 36.0% | 68.9% |
| Q4 25 | 23.3% | 24.1% | ||
| Q3 25 | 17.0% | 5.1% | ||
| Q2 25 | 23.5% | -3.2% | ||
| Q1 25 | 29.5% | -24.3% | ||
| Q4 24 | 21.6% | 24.5% | ||
| Q3 24 | 22.7% | -4.3% | ||
| Q2 24 | 18.0% | -11.5% | ||
| Q1 24 | 18.8% | -10.7% |
| Q4 25 | 11.6% | 25.0% | ||
| Q3 25 | 6.4% | 7.5% | ||
| Q2 25 | 11.5% | -0.9% | ||
| Q1 25 | 19.5% | -21.4% | ||
| Q4 24 | 10.1% | 26.3% | ||
| Q3 24 | 9.8% | -1.6% | ||
| Q2 24 | 6.1% | -8.9% | ||
| Q1 24 | 6.7% | -7.5% |
| Q4 25 | $0.76 | $0.46 | ||
| Q3 25 | $0.41 | $0.10 | ||
| Q2 25 | $0.74 | $-0.01 | ||
| Q1 25 | $1.34 | $-0.23 | ||
| Q4 24 | $0.62 | $0.40 | ||
| Q3 24 | $0.63 | $-0.02 | ||
| Q2 24 | $0.40 | $-0.10 | ||
| Q1 24 | $0.45 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $254.8M | $354.6M |
| Total Assets | $1.3B | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $137.5M | ||
| Q3 25 | $1.2M | $135.4M | ||
| Q2 25 | $1.4M | $116.9M | ||
| Q1 25 | $4.6M | $112.9M | ||
| Q4 24 | $1.2M | $116.2M | ||
| Q3 24 | $1.3M | $101.7M | ||
| Q2 24 | $1.5M | $102.5M | ||
| Q1 24 | $1.7M | $110.6M |
| Q4 25 | $254.8M | $354.6M | ||
| Q3 25 | $242.1M | $321.9M | ||
| Q2 25 | $235.4M | $306.8M | ||
| Q1 25 | $223.1M | $295.5M | ||
| Q4 24 | $208.6M | $292.0M | ||
| Q3 24 | $198.1M | $257.5M | ||
| Q2 24 | $187.9M | $243.0M | ||
| Q1 24 | $179.6M | $233.9M |
| Q4 25 | $1.3B | $488.0M | ||
| Q3 25 | $1.3B | $453.3M | ||
| Q2 25 | $1.3B | $435.6M | ||
| Q1 25 | $1.3B | $424.6M | ||
| Q4 24 | $1.3B | $432.7M | ||
| Q3 24 | $1.3B | $390.4M | ||
| Q2 24 | $1.3B | $376.8M | ||
| Q1 24 | $1.3B | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $15.0M |
| Free Cash FlowOCF − Capex | $6.2M | $12.8M |
| FCF MarginFCF / Revenue | 5.9% | 13.8% |
| Capex IntensityCapex / Revenue | 7.5% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.15× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | $15.0M | ||
| Q3 25 | $24.7M | $22.1M | ||
| Q2 25 | $8.1M | $8.2M | ||
| Q1 25 | $13.8M | $6.6M | ||
| Q4 24 | $9.3M | $22.2M | ||
| Q3 24 | $20.9M | $10.2M | ||
| Q2 24 | $2.2M | $18.5M | ||
| Q1 24 | $19.7M | $7.2M |
| Q4 25 | $6.2M | $12.8M | ||
| Q3 25 | $18.0M | $19.5M | ||
| Q2 25 | $5.2M | $81.0K | ||
| Q1 25 | $10.6M | $-7.6M | ||
| Q4 24 | $4.9M | $8.5M | ||
| Q3 24 | $16.2M | $-9.2M | ||
| Q2 24 | $-1.4M | $1.8M | ||
| Q1 24 | $16.2M | $-6.8M |
| Q4 25 | 5.9% | 13.8% | ||
| Q3 25 | 17.5% | 28.8% | ||
| Q2 25 | 5.1% | 0.1% | ||
| Q1 25 | 9.9% | -14.5% | ||
| Q4 24 | 5.0% | 11.2% | ||
| Q3 24 | 16.1% | -15.9% | ||
| Q2 24 | -1.4% | 3.4% | ||
| Q1 24 | 15.6% | -13.3% |
| Q4 25 | 7.5% | 2.4% | ||
| Q3 25 | 6.5% | 3.9% | ||
| Q2 25 | 2.8% | 12.9% | ||
| Q1 25 | 3.0% | 27.0% | ||
| Q4 24 | 4.5% | 18.3% | ||
| Q3 24 | 4.6% | 33.5% | ||
| Q2 24 | 3.5% | 31.8% | ||
| Q1 24 | 3.4% | 27.3% |
| Q4 25 | 1.15× | 0.65× | ||
| Q3 25 | 3.76× | 4.35× | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | 1.12× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |